Major Canadian Economic Indicators Expected This Week
Dow Jones2026/11/03 11:45All dates are in ET Time.
Tuesday, November 3, 2026 Exp Prev ET/GMT 1100/1600 Bank of Canada Governor Tiff Macklem appears before the House of Commons Standing Committee on Finance
Wednesday, November 4, 2026 Exp Prev ET/GMT 0815/1315 Oct Official International Reserves Monetary Reserves (USD) -2.118B 0830/1330 Sep International merchandise trade Exports, M/M% +2.5% Imports, M/M% -2.0% Trade Balance (CAD) 3.6B 4.199B 0930/1430 Oct Canada Services PMI
Thursday, November 5, 2026 Exp Prev ET/GMT N/A Bank of Canada Governor Tiff Macklem appears before Standing Senate Committee on Banking, Commerce and the Economy N/A Canadian federal budget presentation
Friday, November 6, 2026 Exp Prev ET/GMT 0830/1330 Oct Labour Force Survey Avg Hourly Wages, Y/Y +2.3% Full-Time Jobs, M/M -35400 Jobless Rate 6.5% 6.5% Labor Force, M/M -52900 Net Jobs, M/M +15000 -68300 Participation Rate 64.8% Part-Time Jobs, M/M -32900 1000/1500 Oct Ivey Purchasing Managers Index Ivey PMI 61.9 Ivey PMI-SA 58.2
(END) Dow Jones Newswires
November 03, 2026 06:45 ET (11:45 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
